“…Analogue 17 containing a( 2S,4S)-4-MeGlu residue was therefore synthesized via this approach( Scheme 4, 5.0 mg, overall yield, 12.3 %) in order to probe the effect of substitution at this position on the antimicrobial activity.T he MICs of ad aptomycin analogue containing the substitutions of Lysa tp ositions ix, Glu at position twelve and Trpa tp osition thirteen (Dapt-Lys 6 / Glu 12 /Trp 13 )were reported to be quite close to native daptomycin when assayed against B. subtilis and S. aureus strains, [25] indicatingt hat replacemento fO rn 6 by Lys 6 was beneficial to the antimicrobial activity.Adaptomycin analogue Dapt-Lys 6 /Glu 12 18,c ontaining Lysa tp ositions ix, Glu at position twelve but conserving the Kyn amino acid was thus also prepared (3.5 mg, overall yield, 8.6 %). Due to the fact that mutationo f Kyn 13 to Trp 13 in daptomycin (1)c aused decreased antibacterial activity, [11] the double Kyn substituted analogues Dapt-Kyn 1 / Glu 12 19 containing substitution of Kyn 1 for Trp 1 (3.8 mg, overall yield, 9.4 %) and Dapt-Kyn 1 /Lys 6 /Glu 12 20 (4.8 mg, overall yield, 11.8 %) were also prepared.…”